Paul Nghiem, MD, PhD, University of Washington, shares Immunotherapy & Chemo-Therapy with MCC Response is 60% or More If therapy is Given First Line at Annual Meeting 2018
Immunotherapy & Chemo-Therapy with MCC | Response is 60% or More If therapy is Given First Line
